The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Second-line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam
Open accessAbstract
PURPOSE: Phenytoin (PHT), valproic acid (VPA), or levetiracetam (LEV) are commonly used as second-line treatment of status epilepticus (SE), but comparative studies are not available. METHODS: Among 279 adult SE episodes identified prospectively in our tertiary care hospital over 4 years, we retrospectively identified 187 episodes in which PHT, VPA, or LEV were given after benzodiazepines. Patients with postanoxic SE were not included. Demographics, clinical SE features, failure of second-line treatment to control SE, new handicap, and mortality at hospital discharge were assessed. Uni- and multivariable statistical analyses were applied to compare the three agents. KEY FINDINGS: Each compound was used in about one third of SE episodes. VPA failed to control SE in 25.4%, PHT in 41.4%, and LEV in 48.3% of episodes in which these were prescribed. A deadly etiology was more frequent in the VPA group, whereas SE episodes tended to be more severe in the PHT group. After adjustment for these known SE outcome predictors, LEV failed more often than VPA [odds ratio (OR) 2.69; 95% confidence interval (CI) 1.19-6.08]; 16.8% (95% CI: 6.0-31.4%) of second-line treatment failures could be attributed to LEV. PHT was not statistically different from the other two compounds. Second-line treatment did not seem to influence new handicap and mortality, whereas etiology and the SE Severity Score (STESS) were robust independent predictors. SIGNIFICANCE: Even without significant differences on outcome at discharge, LEV seems less efficient than VPA to control SE after benzodiazepines. A prospective comparative trial is needed to address this potentially concerning finding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Comparison of Four Treatments for Generalized Convulsive Status Epilepticus
Treiman, D. M., Meyers, P. D., Walton, N. Y., Collins, J. F., Colling, C., Rowan, A. J., Handforth, A., Faught, E., Calabrese, V. P., Uthman, B. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809173391202 · Cited by 1,325
PROPORTION OF DISEASE CAUSED OR PREVENTED BY A GIVEN EXPOSURE, TRAIT OR INTERVENTION1
MIETTINEN, O. S. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121617 · Cited by 1,036
Alldredge, B. K., Gelb, A. M., Isaacs, S. M., Corry, M. D., Allen, F., Ulrich, S., Gottwald, M. D., O'Neil, N., Neuhaus, J. M., Segal, M. R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002141 · Cited by 888
Double-blind study of lorazepam and diazepam in status epilepticus
Leppik, L. E. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1983.03330350028021 · Cited by 354
Cited by
Guidelines for the Evaluation and Management of Status Epilepticus
Neurocritical Care Society Status Epilepticus Guideline Writing Committee, Brophy, G. M., Bell, R., Claassen, J., Alldredge, B., Bleck, T. P., Glauser, T., LaRoche, S. M., Riviello, J. J., Shutter, L., et al. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9695-z · Cited by 1,623
Glauser, T., Shinnar, S., Gloss, D., Alldredge, B., Arya, R., Bainbridge, J., Bare, M., Bleck, T., Dodson, W. E., Garrity, L., et al. (2016) · Epilepsy Currents · doi:10.5698/1535-7597-16.1.48 · Cited by 1,280
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
Kapur, J., Elm, J., Chamberlain, J. M., Barsan, W., Cloyd, J., Lowenstein, D., Shinnar, S., Conwit, R., Meinzer, C., Cock, H., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1905795 · Cited by 551
Betjemann, J. P., & Lowenstein, D. H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00042-3 · Cited by 495
Management of refractory status epilepticus in adults: still more questions than answers
Rossetti, A. O., & Lowenstein, D. H. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70187-9 · Cited by 341
Self-citation
Metadata
- Authors
- Alvarez, V., Januel, J.-M., Burnand, B., & Rossetti, A. O.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2011-04-11
- Volume
- 52
- Issue
- 7
- Pages
- 1292-1296
- ISSN
- 0013-9580 (ISSN-L)
- OpenAlex
- W1925921463
- Cited by
- 179
- References
- 4
- FWCI
- 10.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Second-line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam. https://app.cochat.ai/papers/10.1111/j.1528-1167.2011.03056.x
- The paper
- Alvarez, V., Januel, J.-M., Burnand, B., & Rossetti, A. O. (2011). Second-line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam. Epilepsia. https://doi.org/10.1111/j.1528-1167.2011.03056.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.